Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2000
11/22/2000EP1053356A2 Method for diagnosis and treatment of disorders of carbohydrate metabolism
11/22/2000EP1053332A1 Protein
11/22/2000EP1053227A1 Ppar-gamma modulators
11/22/2000EP1053011A1 Mixed micellar pharmaceutical delivery system and method of preparation
11/22/2000EP1053007A2 Methods and compositions for modulating leptin activity
11/22/2000EP1053001A1 Novel mixed amylin activity compounds
11/22/2000EP1052997A1 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation
11/22/2000EP1052994A2 Use of dipeptidylpetidase inhibitors to regulate glucose metabolism
11/22/2000EP1052987A1 Tablets to be crunched or sucked, comprising iron as active principle
11/22/2000EP0666753B1 Use of peptides FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES
11/22/2000EP0586535B1 Methods and compositions based on inhibition of cell invasion and fibrosis by dextran sulfate
11/22/2000CN1274344A Novel vitamin D analogues
11/22/2000CN1274289A Compsns. comprising comjugates of stable, active, human ob protein with antibody FC chain and methods
11/22/2000CN1274285A Alpha-ketoamide multicatalytic protease inhibitors
11/22/2000CN1274282A Treatment of diabetes with thiazolidinedione and Alpha-glucosidase inhibitor
11/22/2000CN1273967A Novel substituted dimeric compounds, its preparing process and medicinal compsns. containing same
11/22/2000CN1273859A Buccal lozenge for activating intelligent genes and increasing intelligence quotient
11/22/2000CN1273842A Multi-nutrient instant particles for refreshing brain, loosing weight, making bone stronger, blackening hair and elongating life
11/22/2000CN1273830A Chinese medicine for treating diabetes
11/22/2000CN1273828A Instant particles for supplementing nutrients needed per day
11/22/2000CN1058715C Thiophene compound, its prepn. method and medicinal compsn. containing same
11/22/2000CN1058710C Benzamide derivatives, process for prepn. thereof and pharmaceutical compsn. comprising same
11/22/2000CN1058614C Galenic prepn. compsn.
11/21/2000US6150557 Compounds
11/21/2000US6150556 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/21/2000US6150389 Antidepressants; treating elevated intraocular pressure, e.g., glaucoma; antidiabetic agents for non-insulin dependent diabetes, sexual disorders, e.g., male impotence and obesity; e.g. trans-2-(3-phenyl-bicyclo(2.2.1)heptyl)-2-aminooxazoline
11/21/2000US6150388 Indole derivatives as 5-HT1 agonists
11/21/2000US6150384 Pharmaceutical composition
11/21/2000US6150383 Comprising an insulin sensitivity enhancer in combination with one or more other antidiabetics differing from the enhancer in mechanism of action; lipid/glycometabolism disorders; antidiabetic agents; side effect reduction
11/21/2000US6150376 Bi- and tri-cyclic aza compounds and their uses
11/21/2000US6150373 Bicyclic nitrogen heterocycles
11/21/2000US6150346 Method and composition for treating or preventing osteoporosis
11/21/2000US6150332 Alpha1-antitrypsin and peptide fragments and derivatives thereof are used to upregulate low density lipoprotein cholesterol receptor levels in the liver, resulting in a decrease in circulating ldl cholesterol levels
11/21/2000US6150153 Thermostable trehalose-releasing enzyme
11/21/2000US6149915 Administering a herb salviae miltiorrhizae radix
11/21/2000CA2187309C Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors
11/21/2000CA2105502C Insulin secretion stimulating composition for the treatment of non-insulin-dependent diabetes
11/21/2000CA2098294C Directly compressible xylitol and method
11/21/2000CA2020477C Sustained release formulations of water soluble peptides
11/16/2000WO2000068386A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000WO2000068385A2 Novel nucleic acids and proteins with growth hormone activity
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068246A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000WO2000068224A1 Substituted benzolactam compounds
11/16/2000WO2000068213A1 Substituted bicyclic compounds
11/16/2000WO2000068209A2 1,5-benzodiazepine derivatives as cck-a receptor agonists
11/16/2000WO2000068208A1 Pyrimidinones derivatives for the treatment of atherosclerosis
11/16/2000WO2000068206A1 Heterocyclically substituted benzimidazoles, the production and application thereof
11/16/2000WO2000068200A1 Quinoline derivatives as inhibitors of mek enzymes
11/16/2000WO2000068188A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000067796A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/16/2000WO2000067761A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000WO2000067752A1 Use of succinic acid derivatives to obtain a medicine for treating inflammation
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000067697A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000WO2000039285A3 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000037057A3 Novel formulations comprising lipid-regulating agents
11/16/2000WO2000034468A3 Muc-1 antagonists and methods of treating immune disorders
11/16/2000WO2000034331A3 Analogues of glp-1
11/16/2000WO2000032180A3 Antihypertriglyceridemic, antihyperglycemic, anti-angiogenic and wound healing substituted indolealkanoic acids
11/16/2000WO2000027377A3 Phosphinate peptide analogs for the treatment of fibrotic disorders
11/16/2000WO2000026370A3 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/16/2000WO2000020448A3 Nlk1 -interacting proteins
11/16/2000WO2000009549A3 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
11/16/2000WO2000006138A3 Use of moclobemide for treating pain and other diseases
11/16/2000WO2000001713A3 Diacylglycerol acyl transferase proteins
11/16/2000DE19920247A1 Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung Medicaments with an amount of compounds having a nitrogen-oxygen heterocycle as active ingredient and their use
11/16/2000CA2374237A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000CA2373851A1 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000CA2373443A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000CA2373079A1 Substituted benzolactam compounds
11/16/2000CA2372871A1 Novel nucleic acids and proteins with growth hormone activity
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372805A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000CA2370838A1 Quinoline derivatives as inhibitors of mek enzymes
11/16/2000CA2370801A1 1,5-benzodiazepine derivatives as cck-a receptor agonists
11/15/2000EP1052285A2 Method of inducing an antigen-specific anticytotoxic cell
11/15/2000EP1052254A1 Nitrogenous heterocyclic derivatives and medicine thereof
11/15/2000EP1051977A1 Release-sustaining agent for drugs and sustained-release pharmaceutical composition
11/15/2000EP1051975A1 Dry mix formulation for bisphosphonic acids
11/15/2000EP1051972A1 Nitric oxide donor composition and method for treatment of anal disorders
11/15/2000EP1051429A1 Ldl related protein and uses thereof
11/15/2000EP1051415A1 Benzamide derivatives as vasopressin antagonists
11/15/2000EP1051403A1 Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
11/15/2000EP1051193A1 Anhydrous topical skin preparations
11/15/2000EP1051191A2 Cd154 blockade therapy for pancreatic islet tissue transplantation
11/15/2000EP1051186A2 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
11/15/2000EP1051167A1 Pharmaceutical uses of optically pure (-) -bupropion
11/15/2000EP1051166A1 Pharmaceutical uses of optically pure (+) -bupropion
11/15/2000EP1051165A2 Mitochondria protecting agents for treating mitochondria associated diseases
11/15/2000EP1051161A1 Method for treating alzheimer's disease
11/15/2000EP0717635B1 Methods for regulating gastrointestinal motility
11/15/2000CN1273584A Imidazolyl-cyclic acetals
11/15/2000CN1273531A Chromium/biotin treatment of type II diabetes
11/15/2000CN1273528A Novel heterocyclic analogs of diphenylethylene compounds
11/15/2000CN1273108A Medicine 'Tangniaoke' for treating diabetes
11/15/2000CN1273093A Hypoglycemix Xinxuekang and itspreparing process
11/15/2000CN1058487C 1,5-benzodiazepine derivatives having CCK antagoistic or agonistic activity
11/15/2000CN1058403C Drug composition for treating 'Middle-Xiao' type diabetes
1 ... 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 ... 1298